Literature DB >> 17507314

Spherical crystals of celecoxib to improve solubility, dissolution rate and micromeritic properties.

Venkadari Rammohan Gupta1, Srinivas Mutalik, Madhobhai M Patel, Girish K Jani.   

Abstract

Celecoxib spherical agglomerates were prepared with polyvinylpyrrolidone (PVP) using acetone, water and chloroform as solvent, non-solvent and bridging liquid, respectively. The agglomerates were characterized by differential scanning calorimetry (DSC), X-ray diffraction (XRD), IR spectroscopic studies and scanning electron microscopy (SEM). The IR spectroscopy and DSC results indicated the absence of any interactions between drug and additives. XRD studies showed a decrease in crystallinity in agglomerates. The crystals exhibited significantly improved micromeritic properties compared to pure drug. The loading efficiency (% or mg drug per 100 mg crystals) was in the range of 93.9 +/- 2.3 and 97.3 +/- 1.3% (n = 3) with all formulations. The aqueous solubility and dissolution rate of the drug from crystals was significantly (p < 0.05) increased (nearly two times). The solubility and in vitro drug release rates increased with an increase in PVP concentration (from 2.5 to 10%). The SEM studies showed that the crystal posseses a good spherical shape with smooth and regular surface.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17507314     DOI: 10.2478/v10007-007-0014-8

Source DB:  PubMed          Journal:  Acta Pharm        ISSN: 1330-0075            Impact factor:   2.230


  11 in total

1.  In vitro and in vivo evaluation of proniosomes containing celecoxib for oral administration.

Authors:  Mohamed Nasr
Journal:  AAPS PharmSciTech       Date:  2010-01-08       Impact factor: 3.246

2.  Influence of microcrystal formulation on in vivo absorption of celecoxib in rats.

Authors:  Mohamed Nasr
Journal:  AAPS PharmSciTech       Date:  2013-03-30       Impact factor: 3.246

3.  Formulation Development of Spherical Crystal Agglomerates of Itraconazole for Preparation of Directly Compressible Tablets with Enhanced Bioavailability.

Authors:  Janki Fadke; Jagruti Desai; Hetal Thakkar
Journal:  AAPS PharmSciTech       Date:  2015-05-20       Impact factor: 3.246

4.  Agglomeration of Celecoxib by Quasi Emulsion Solvent Diffusion Method: Effect of Stabilizer.

Authors:  Maryam Maghsoodi; Ali Nokhodchi
Journal:  Adv Pharm Bull       Date:  2016-12-22

5.  Experimental Design to Predict Process Variables in the Microcrystals of Celecoxib for Dissolution Rate Enhancement Using Response Surface Methodology.

Authors:  Mitra Jelvehgari; Hadi Valizadeh; Seyed Hassan Montazam; Sanam Abbaszadeh
Journal:  Adv Pharm Bull       Date:  2015-06-01

6.  Preparation and In Vitro Evaluation of Ibuprofen Spherical Agglomerates.

Authors:  Nagaraju Ravouru; Subhash Chandra Bose Penjuri; Saritha Damineni; Raja Lakshmi Muni; Srikanth Reddy Poreddy
Journal:  Turk J Pharm Sci       Date:  2018-04-02

7.  Enhanced dissolution rate of felodipine using spherical agglomeration with Inutec SP1 by quasi emulsion solvent diffusion method.

Authors:  A R Tapas; P S Kawtikwar; D M Sakarkar
Journal:  Res Pharm Sci       Date:  2009-07

8.  Effect of drying phase on the agglomerates prepared by spherical crystallization.

Authors:  Maryam Maghsoodi; Zahra Yari
Journal:  Iran J Pharm Res       Date:  2015       Impact factor: 1.696

9.  Effect of temperature on wet agglomeration of crystals.

Authors:  Maryam Maghsoodi; Zahra Yari
Journal:  Iran J Basic Med Sci       Date:  2014-05       Impact factor: 2.699

10.  Preparation and characterization of celecoxib solid dispersions; comparison of poloxamer-188 and PVP-K30 as carriers.

Authors:  Alireza Homayouni; Fatemeh Sadeghi; Ali Nokhodchi; Jaleh Varshosaz; Hadi Afrasiabi Garekani
Journal:  Iran J Basic Med Sci       Date:  2014-05       Impact factor: 2.699

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.